Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Louisa Degenhardt, Fiona J Charlson, Alize J Ferrari, et al.
The Lancet Psychiatry (2018) Vol. 5, Iss. 12, pp. 987-1012
Open Access | Times Cited: 1242

Showing 26-50 of 1242 citing articles:

Medication overuse headache
Sait Ashina, Gisela M. Terwindt, Timothy J. Steiner, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 89
Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study
Chengsheng Ju, Li Wei, Kenneth K. C. Man, et al.
The Lancet Public Health (2022) Vol. 7, Iss. 4, pp. e335-e346
Open Access | Times Cited: 81
Therapeutic effect of psilocybin in addiction: A systematic review
Pim B. van der Meer, Juan José Fuentes, Ad A. Kaptein, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 76
Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Min Seo Kim, Jimin Hwang, Dong Keon Yon, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 10, pp. e1553-e1565
Open Access | Times Cited: 76
Western diets and chronic diseases
Timon E. Adolph, Herbert Tilg
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2133-2147
Closed Access | Times Cited: 23
Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Juan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 23
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, et al.
Addiction (2025)
Open Access | Times Cited: 2
The prevalence of multimorbidity and associations with lifestyle factors among middle-aged Canadians: an analysis of Canadian Longitudinal Study on Aging data
Mohammad Nazmus Sakib, Shahin Shooshtari, Philip St. John, et al.
BMC Public Health (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 139
Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis
Rebecca McKetin, Janni Leung, Emily Stockings, et al.
EClinicalMedicine (2019) Vol. 16, pp. 81-97
Open Access | Times Cited: 139
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review
Jasmina Mallet, Caroline Dubertret, Yann Le Strat
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110070-110070
Open Access | Times Cited: 137
Treatment rates for alcohol use disorders: a systematic review and meta‐analysis
Tesfa Mekonen, Gary Chan, Jason P. Connor, et al.
Addiction (2020) Vol. 116, Iss. 10, pp. 2617-2634
Closed Access | Times Cited: 135
All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids
Sarah Larney, Lucy Thi Tran, Janni Leung, et al.
JAMA Psychiatry (2019) Vol. 77, Iss. 5, pp. 493-493
Open Access | Times Cited: 118
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence
Valentina Lorenzetti, Eva Hoch, Wayne Hall
European Neuropsychopharmacology (2020) Vol. 36, pp. 169-180
Closed Access | Times Cited: 115
Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids
Anees Bahji, Callum Stephenson, Richard Tyo, et al.
JAMA Network Open (2020) Vol. 3, Iss. 4, pp. e202370-e202370
Open Access | Times Cited: 112
Heavy cannabis use, dependence and the brain: a clinical perspective
Emese Kroon, Lauren Kuhns, Eva Hoch, et al.
Addiction (2019) Vol. 115, Iss. 3, pp. 559-572
Open Access | Times Cited: 104
Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis
Pedro Rafael Figueiredo, Serenella Tolomeo, J. Douglas Steele, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 358-369
Open Access | Times Cited: 103
Heroin use cannot be measured adequately with a general population survey
Peter Reuter, Jonathan P. Caulkins, Greg Midgette
Addiction (2021) Vol. 116, Iss. 10, pp. 2600-2609
Closed Access | Times Cited: 102
Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective
Natasha Hall, Long Khanh‐Dao Le, Ishani Majmudar, et al.
Drug and Alcohol Dependence (2021) Vol. 221, pp. 108651-108651
Closed Access | Times Cited: 100
Recent Efforts to Dissect the Genetic Basis of Alcohol Use and Abuse
Sandra Sanchez‐Roige, Abraham A. Palmer, Toni‐Kim Clarke
Biological Psychiatry (2019) Vol. 87, Iss. 7, pp. 609-618
Open Access | Times Cited: 93
New alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders
Εvangelos Εvangelou, He Gao, Congying Chu, et al.
Nature Human Behaviour (2019) Vol. 3, Iss. 9, pp. 950-961
Open Access | Times Cited: 92
International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis
Anees Bahji, Callum Stephenson
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 17, pp. 3095-3095
Open Access | Times Cited: 89
Cannabis use in Adolescence and Risk of Psychosis: Are there Factors that Moderate this Relationship? A Systematic Review and Meta-Analysis
Sarah Kanana Kiburi, Keneilwe Molebatsi, Vuyokazi Ntlantsana, et al.
Substance Abuse (2021) Vol. 42, Iss. 4, pp. 527-542
Closed Access | Times Cited: 87
The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates
Alexander S. Hatoum, Emma C. Johnson, Sarah M. C. Colbert, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 10, pp. 1739-1745
Open Access | Times Cited: 86
Developing neuroscience-based treatments for alcohol addiction: A matter of choice?
Markus Heilig, Eric Augier, Simone Pfarr, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 85
Alcohol’s Impact on the Gut and Liver
Keith Pohl, Prebashan Moodley, Ashwin Dhanda
Nutrients (2021) Vol. 13, Iss. 9, pp. 3170-3170
Open Access | Times Cited: 78

Scroll to top